Founders Capital Management (Texas)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-130
| Closed | -$25.2K | – | 371 |
|
|
2024
Q3 | $25.2K | Hold |
130
| – | – | 0.02% | 206 |
|
|
2024
Q2 | $30.1K | Hold |
130
| – | – | 0.02% | 189 |
|
|
2024
Q1 | $28K | Hold |
130
| – | – | 0.02% | 187 |
|
|
2023
Q4 | $33.6K | Hold |
130
| – | – | 0.02% | 179 |
|
|
2023
Q3 | $33.4K | Hold |
130
| – | – | 0.03% | 177 |
|
|
2023
Q2 | $37K | Hold |
130
| – | – | 0.03% | 163 |
|
|
2023
Q1 | $36K | Hold |
130
| – | – | 0.03% | 163 |
|
|
2022
Q4 | $36K | Hold |
130
| – | – | 0.03% | 157 |
|
|
2022
Q3 | $35K | Hold |
130
| – | – | 0.03% | 152 |
|
|
2022
Q2 | $27K | Hold |
130
| – | – | 0.02% | 192 |
|
|
2022
Q1 | $31K | Hold |
130
| – | – | 0.02% | 163 |
|
|
2021
Q4 | $31K | Hold |
130
| – | – | 0.02% | 163 |
|
|
2021
Q3 | $37K | Buy |
+130
| New | +$37K | 0.03% | 146 |
|